Delivery Order SPE2DB22D2206-SPE2DB25FGL30
Award Date
4/7/25
Potential Completion Date
4/8/25
Potential Value
$5.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,139.66 firm fixed-price contract is for the delivery of 400 mg/200 mL ropivacaine 0.2% injectable medication. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running through November 2026. This IDC...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,775.55, is for the delivery of Ropivacaine 0.2% 400 mg/200 ml (200 ml) medical supplies. The contract has an ultimate completion date of May 23, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,633.30, is for the delivery of Ropivacaine 0.2% 400 mg/200 ml injections. The contract is a firm fixed-price, delivery order type with a completion date of February 25, 2025. No set-aside designation was used for this award. AmerisourceBergen holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 400 mg/200 mL of Ropivacaine 0.2% medication, with a ceiling value of $1,346.51 and a completion date of June 5, 2025. The contract is a firm fixed price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This is a $1,880.49 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 400 mg/200 mL Ropivacaine 0.2% medication, with a performance period through May 27, 2025. The contract has no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,513.30, is for the delivery of Ropivacaine 0.2% 400 mg/200 ml injectable medication. It is a firm fixed-price delivery order contract with a period of performance through July 2024. This contract award is not designated as a set-aside and represents open competition. AmerisourceBergen also holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 200 mg/100 mL of the drug Ropivacaine 0.2%, with a ceiling value of $1,276.43. The contract is a firm fixed-price, non-set-aside award with a completion date of June 9, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 400 mg/200 mL bottles of the pharmaceutical drug Ropivacaine 0.2%. The contract is a Delivery Order valued at $2,734.75 with a firm fixed price, and has an ultimate completion date of March 12, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,851.72, is for the supply of 400 mg/200 mL of Ropivacaine 0.2% in a 200 mL dosage. The delivery order was awarded on May 16, 2023, with a completion date of May 17, 2023. This contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 0.5% ropivacaine 150 mg/30 ml (30 ml) at a ceiling value of $2,104.56. The delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....